Literature DB >> 31895720

ACG Clinical Guideline: Disorders of the Hepatic and Mesenteric Circulation.

Douglas A Simonetto1, Ashwani K Singal2, Guadalupe Garcia-Tsao3, Stephen H Caldwell4, Joseph Ahn5, Patrick S Kamath1.   

Abstract

Disorders of the mesenteric, portal, and hepatic veins and mesenteric and hepatic arteries have important clinical consequences and may lead to acute liver failure, chronic liver disease, noncirrhotic portal hypertension, cirrhosis, and hepatocellular carcinoma. Although literature in the field of vascular liver disorders is scant, these disorders are common in clinical practice, and general practitioners, gastroenterologists, and hepatologists may benefit from expert guidance and recommendations for management of these conditions. These guidelines represent the official practice recommendations of the American College of Gastroenterology. Key concept statements based on author expert opinion and review of literature and specific recommendations based on PICO/GRADE analysis have been developed to aid in the management of vascular liver disorders. These recommendations and guidelines should be tailored to individual patients and circumstances in routine clinical practice.

Entities:  

Mesh:

Year:  2020        PMID: 31895720     DOI: 10.14309/ajg.0000000000000486

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  20 in total

1.  Acute Portal Vein Thrombosis in SARS-CoV-2 Infection: A Case Report.

Authors:  Vincenzo La Mura; Andrea Artoni; Ida Martinelli; Raffaella Rossio; Roberta Gualtierotti; Gabriele Ghigliazza; Stefano Fusco; Anna Maria Ierardi; Maria Carmela Andrisani; Gianpaolo Carrafiello; Flora Peyvandi
Journal:  Am J Gastroenterol       Date:  2020-05-27       Impact factor: 10.864

2.  Rebalanced hemostasis in liver disease: a misunderstood coagulopathy.

Authors:  Lara N Roberts
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2021-12-10

3.  Clinical predictors for thrombus progression in cirrhotic patients with untreated splanchnic vein thrombosis.

Authors:  Hannah McMurry; Jean M G Sabile; Benjamin Elstrott; Boris Chobrutskiy; Ajay Mohinani; Sarah Patel; Sonia Gowda; Kylee Martens; Joseph Shatzel
Journal:  Thromb Res       Date:  2022-05-27       Impact factor: 10.407

4.  Use of FFP to correct INR: time to drop this from the decompensated cirrhosis care bundle?

Authors:  Ben Lawrence; Keith Siau
Journal:  Frontline Gastroenterol       Date:  2022-02-10

5.  Small Bowel Perforation Secondary to Portal Vein Thrombosis.

Authors:  Arthur Cecchini; Ahmad Othman; Koushik Sanku; Amanda Cecchini; Deidra Pierce
Journal:  Cureus       Date:  2022-06-13

Review 6.  Anticoagulation in Cirrhosis: Evidence for the Treatment of Portal Vein Thrombosis and Applications for Prophylactic Therapy.

Authors:  Kylee Martens; Hannah S McMurry; Steven Koprowski; Justine Hum; Jessica Haraga; Janice H Jou; Joseph J Shatzel
Journal:  J Clin Gastroenterol       Date:  2022-04-29       Impact factor: 3.174

7.  Anticoagulation in splanchnic and cerebral vein thrombosis: An international vignette-based survey.

Authors:  Nicoletta Riva; Marc Carrier; Alex Gatt; Walter Ageno
Journal:  Res Pract Thromb Haemost       Date:  2020-09-11

8.  Acute Portal Vein Thrombosis in SARS-CoV-2 Infection: A Case Report.

Authors:  Vincenzo La Mura; Andrea Artoni; Ida Martinelli; Raffaella Rossio; Roberta Gualtierotti; Gabriele Ghigliazza; Stefano Fusco; Anna Maria Ierardi; Maria Carmela Andrisani; Gianpaolo Carrafiello; Flora Peyvandi
Journal:  Am J Gastroenterol       Date:  2020-07-01       Impact factor: 10.864

9.  Assessing the periprocedural magnitude of platelet count change in response to lusutrombopag.

Authors:  Robert S Brown; Michio Imawari; Namiki Izumi; Yukio Osaki; Roy Bentley; Toshimitsu Ochiai; Takeshi Kano; Markus Peck-Radosavljevic
Journal:  JHEP Rep       Date:  2021-01-13

10.  Anticoagulation Favors Thrombus Recanalization and Survival in Patients With Liver Cirrhosis and Portal Vein Thrombosis: Results of a Meta-Analysis.

Authors:  Le Wang; Xiaozhong Guo; Xiangbo Xu; Valerio De Stefano; Aurelie Plessier; Carlos Noronha Ferreira; Xingshun Qi
Journal:  Adv Ther       Date:  2020-11-05       Impact factor: 3.845

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.